Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01028131 · ClinicalTrials.gov registry record · Phase 2
Computer-Assisted Intervention for Smoking During Pregnancy
A Phase 2 study of Smoking, sponsored by Wayne State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT01028131: Completed Phase 2 study of Smoking, sponsored by Wayne State University.
NCT01028131 is a Phase 2 study of Smoking that has completed, run by Wayne State University. The registered enrollment target is 110 participants, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01028131, a Phase 2 study of Smoking, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will develop: 1. Develop the computer-based brief intervention and Contingency Management (CM) components, with repeated feedback from experts, prenatal clinic staff, and participants. 2. Recruit 110 pregnant women who are actively smoking, and randomly assign recruited women to Brief Intervention, CM, combined, or control conditions. 3. Conduct follow-up evaluation at 12 weeks post-intervention to measure self-reported smoking, breath carbon monoxide (CO), and urinary cotinine levels. 4. Collect data regarding birth outcomes and evaluate the feasibility of various methods of post-partum follow-up.
Primary Outcome
All participants were analyzed as assigned. Total N was determined primarily by resource availability in this Stage Ib trial. Number represents number of abstinent participants in each condition.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
- BEHAVIORAL Computer-delivered brief intervention (5As)
Study Locations (1)
Michigan
- Wayne State University-Detroit Medical Center - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-01 |
| Phase | Phase 2 |
What the finished NCT01028131 record still lists
NCT01028131 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 2 interventions - of which Contingency Management is the first listed.
NCT01028131 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01028131 about?
NCT01028131 is a clinical study titled "Computer-Assisted Intervention for Smoking During Pregnancy". This study will develop: 1. Develop the computer-based brief intervention and Contingency Management (CM) components, with repeated feedback from experts, prenatal clinic staff, and participants. 2. Recruit 110 pregnant women who are actively smoking, and randomly assign recruited women to Brief In...
What is the current status of trial NCT01028131?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2007-06. Estimated completion is 2010-01.
What conditions does trial NCT01028131 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT01028131?
The interventions under investigation include: Contingency Management (BEHAVIORAL), Computer-delivered brief intervention (5As) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01028131?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01028131 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01028131's enrollment target sits among peer trials
110 71st of 123 higher than 53 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence
RECRUITING · Phase 2
-
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
RECRUITING · Phase 2
-
App for Reducing Cravings to Smoke
RECRUITING · Phase 2
-
Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava
ACTIVE NOT RECRUITING · Phase 2
-
Proactive Health Intervention for Tobacco Users (Get PHIT)
COMPLETED · Phase 2
-
Oxidative Stress and Vitamin E Requirements
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia